26 January 2021
Biotangents have been selected as finalists in the Animal Health Innovation 2021 Showcase in the Production Animal & Animal Agri-Tech category to highlight the development of our industry-changing mastitis on-farm/in-clinic diagnostic device for which we are currently seeking a strategic corporate partner.
Director of Commercialisation, Rachel Mallet, will present our proprietary solution, which will differentiate between key mastitis pathogens, within 3 hours, enabling targeted and responsible use of antimicrobials.
Animal Health Innovation Europe is the sector’s premier investment forum in Europe, showcasing the most exciting innovators in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners.
The Innovation Showcase is a globally recognised opportunity for emerging companies to present in front of the industry’s most influential figures and investors. 20 start-ups, hand-picked by the Selection Committee, which includes Bruce Taillon (Senior Director, External Innovation at Elanco), Maarten Goossens (Co-Founder & Principal at Anterra Capital) and Spencer Swayze (Managing Director at Paine Schwartz Partners, LLC), take to the virtual main stage to introduce themselves, their innovations and their achievements.
This year, the 20 presenting companies will be split into two distinguishable sections:
10 start-ups will present their innovations in the companion animal & pet care space.
10 start-ups will present their innovations in the production animal & animal agri-tech space.
Winners will also be announced at Animal Health Innovation Europe, which is taking place online on 22-23 February 2021. Join us for our showcase appearance online by booking your ticket here .
Comments